Education
About Us
Working with TipRanks
Follow Us
RUA Life Sciences (GB:RUA)
LSE:RUA
RESEARCH TOOLSreports
Total Valuation
RUA Life Sciences has a market cap or net worth of £7.14M. The enterprise value is 5.90M.
Market Cap£7.14M
Enterprise Value5.90M
Share Statistics
RUA Life Sciences has 62,060,272 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding62,060,272
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RUA Life Sciences’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -17.86%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-17.86%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee54.77K
Profits Per Employee-36.00K
Employee Count40
Asset Turnover0.27
Inventory Turnover4.24
Valuation Ratios
The current PE Ratio of RUA Life Sciences is -2.04. RUA Life Sciences’s PEG ratio is 0.04.
PE Ratio-2.04
PS Ratio3.51
PB Ratio0.41
Price to Fair Value0.41
Price to FCF-2.12
Price to Operating Cash Flow-2.21
PEG Ratio0.04
Income Statement
In the last 12 months, RUA Life Sciences had revenue of 2.19M and earned -1.44M in profits. Earnings per share was -0.04.
Revenue2.19M
Gross Profit1.72M
Operating Income-1.94M
Pretax Income-2.02M
Net Income-1.44M
EBITDA-1.57M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -1.35M and capital expenditures -55.00K, giving a free cash flow of -1.40M billion.
Operating Cash Flow-1.35M
Free Cash Flow-1.40M
Free Cash Flow per Share-0.02
Dividends & Yields
RUA Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change12.20%
50-Day Moving Average12.26
200-Day Moving Average11.93
Relative Strength Index (RSI)65.76
Average Volume (3m)91.89K
Important Dates
RUA Life Sciences upcoming earnings date is Jul 22, 2025, TBA Not Confirmed.
Last Earnings DateDec 11, 2024
Next Earnings DateJul 22, 2025
Ex-Dividend Date―
Financial Position
RUA Life Sciences as a current ratio of 9.01, with Debt / Equity ratio of 5.42%
Current Ratio9.01
Quick Ratio8.81
Debt to Market Cap0.06
Net Debt to EBITDA2.25
Interest Coverage Ratio-23.34
Taxes
In the past 12 months, RUA Life Sciences has paid -580.00K in taxes.
Income Tax-580.00K
Effective Tax Rate0.29
Enterprise Valuation
RUA Life Sciences EV to EBITDA ratio is 0.38, with an EV/FCF ratio of 0.44.
EV to Sales-0.28
EV to EBITDA0.38
EV to Free Cash Flow0.44
EV to Operating Cash Flow0.46
Balance Sheet
RUA Life Sciences has £3.93M in cash and marketable securities with £0.00 in debt, giving a net cash position of -£3.54M billion.
Cash & Marketable Securities£3.93M
Total Debt£0.00
Net Cash-£3.54M
Net Cash Per Share-£0.06
Tangible Book Value Per Share£0.19
Margins
Gross margin is 69.88%, with operating margin of -88.41%, and net profit margin of -65.72%.
Gross Margin69.88%
Operating Margin-88.41%
Pretax Margin-92.20%
Net Profit Margin-65.72%
EBITDA Margin-71.79%
EBIT Margin-88.41%
Analyst Forecast
The average price target for RUA Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast56.29%
EPS Growth Forecast―